BioMed Central | Articles which cite: A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment.

home journals A-Z subject areas advanced search authors reviewers libraries about my BioMed Central

printer friendly

to [Help]

PubMed Central articles that cite the above article:

1.	An overview of prognostic factors for long-term survivors of breast cancer. Soerjomataram I, Louwman MW, Ribot JG, Roukema JA, Coebergh JW Breast Cancer Res Treat 2008 Feb, 107:309-30 [PubMed Central] [PubMed] [Related articles]
2.	BRCA1/2 associated hereditary breast cancer. Teng LS, Zheng Y, Wang HH J Zhejiang Univ Sci B 2008 Feb, 9:85-9 [PubMed Central] [PubMed] [Related articles]
3.	Potential excess mortality in BRCA1/2 mutation carriers beyond breast, ovarian, prostate, and pancreatic cancers, and melanoma. Mai PL, Chatterjee N, Hartge P, Tucker M, Brody L, Struewing JP, Wacholder S PLoS One 2009, 4:e4812 [PubMed Central] [PubMed] [Related articles]
4.	Prevalence and characteristics of pancreatic cancer in families with BRCA1 and BRCA2 mutations. Kim DH, Crawford B, Ziegler J, Beattie MS Fam Cancer 2009, 8:153-8 [PubMed Central] [PubMed] [Related articles]
5.	BRCA1 promoter methylation is associated with increased mortality among women with breast cancer. Xu X, Gammon MD, Zhang Y, Bestor TH, Zeisel SH, Wetmur JG, Wallenstein S, Bradshaw PT, Garbowski G, Teitelbaum SL, Neugut AI, Santella RM, Chen J Breast Cancer Res Treat 2009 May, 115:397-404 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 4 articles in BioMed Central

You can also check ISI Web of Science for additional citations (subscription required)

printer friendly

to [Help]